Foley Partners Judith Waltz and Antoinette Konski authored an article that appeared in Genetic Engineering & Biotechnology News on July 1, 2011 titled “HHS Puts Stamp on Personalized Medicine.” The authors discuss the Department of Health and Human Services’ (HHS) influence on personalized medicine, stating that HHS has received legal and monetary support which should allow for alternative and creative approaches to better personalized healthcare. They add that HHS will also play a critical role in the regulation of direct-to-consumer marketing of genetic tests, noting that it is important for those in the personalized medicine sector to familiarize themselves with the multiple roles that HHS plays.
Author(s)
Related Insights
07 February 2025
Health Care Law Today
The Colorado AI Act: Implications for Health Care Providers
Artificial intelligence (AI) is increasingly being integrated into health care operations, from administrative functions such as scheduling and billing to clinical decision-making, including diagnosis and treatment recommendations. Although AI offers significant benefits, concerns regarding bias, transparency, and accountability have prompted regulatory responses.
07 February 2025
Trump Tariffs 2.0: FAQs on How Your Contract Comes into Play
Video FAQ: Does your contract protect you? The Trump administration’s tariffs have reshaped global trade—but how do they impact your contracts? From force majeure to price adjustment clauses, understanding these provisions is critical for protecting your business.
05 February 2025
Manufacturing Industry Advisor
Foley Automotive Update
Foley is here to help you through all aspects of rethinking your long-term business strategies, investments, partnerships, and technology. Contact the authors, your Foley relationship partner, or our Automotive Team to discuss and learn more.